Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathology

Abstract INTRODUCTION This study evaluated the performance of the Lumipulse plasma beta‐amyloid (Aβ) 42/40 and pTau181 compared to other assays to detect an abnormal amyloid‐positron emission tomography (PET). METHODS Plasma samples from cognitively unimpaired (N = 179) and MCI/AD dementia (N = 36)...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Daniel J. Figdore, Heather J. Wiste, Joshua A. Bornhorst, Randall J. Bateman, Yan Li, Jonathan Graff‐Radford, David S. Knopman, Prashanthi Vemuri, Val J. Lowe, Clifford R. Jack Jr, Ronald C. Petersen, Alicia Algeciras‐Schimnich
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2024-01-01
Serie:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Soggetti:	Alzheimer's disease blood biomarkers amyloid beta amyloid‐PET Aβ42/Aβ40 plasma pTau pTau181
Accesso online:	https://doi.org/10.1002/dad2.12545
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!